Virginia Retirement Systems Et Al Kiniksa Pharmaceuticals, Ltd. Transaction History
Virginia Retirement Systems Et Al
- $10.1 Billion
- Q3 2023
A detailed history of Virginia Retirement Systems Et Al transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 25,200 shares of KNSA stock, worth $639,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,200
Previous 32,300
21.98%
Holding current value
$639,324
Previous $454,000
3.74%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KNSA
# of Institutions
11Shares Held
1.89MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$38.5 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$5.14 Million2.82% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$1 Million0.0% of portfolio
-
Barclays PLC London, X034.8KShares$883,8650.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$761,1000.56% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $875M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...